Sanofi’s Nexviazyme Shows Positive Phase 3 Results in Infantile Pompe Diseas
Sanofi has reported positive Phase 3 results for Nexviazyme, also known as avalglucosidase alfa, in infants with infantile-onset Pompe disease, a rare and life-threatening genetic…
Read More...
Read More...
